Literature DB >> 2140835

Lipoprotein (a). Heterogeneity and biological relevance.

A M Scanu1, G M Fless.   

Abstract

Mesh:

Substances:

Year:  1990        PMID: 2140835      PMCID: PMC296630          DOI: 10.1172/JCI114625

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


× No keyword cloud information.
  59 in total

1.  A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

Authors:  K BERG
Journal:  Acta Pathol Microbiol Scand       Date:  1963

2.  Isolation, characterization, and uptake in human fibroblasts of an apo(a)-free lipoprotein obtained on reduction of lipoprotein(a).

Authors:  V W Armstrong; A K Walli; D Seidel
Journal:  J Lipid Res       Date:  1985-11       Impact factor: 5.922

3.  Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

Authors:  A Murai; T Miyahara; N Fujimoto; M Matsuda; M Kameyama
Journal:  Atherosclerosis       Date:  1986-02       Impact factor: 5.162

4.  Heterogeneity of human plasma lipoprotein (a). Isolation and characterization of the lipoprotein subspecies and their apoproteins.

Authors:  G M Fless; C A Rolih; A M Scanu
Journal:  J Biol Chem       Date:  1984-09-25       Impact factor: 5.157

5.  Fat feeding in humans induces lipoproteins of density less than 1.006 that are enriched in apolipoprotein [a] and that cause lipid accumulation in macrophages.

Authors:  T P Bersot; T L Innerarity; R E Pitas; S C Rall; K H Weisgraber; R W Mahley
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

6.  A dominant role of lipoprotein(a) in the investigation and evaluation of parameters indicating the development of cervical atherosclerosis.

Authors:  P Költringer; G Jürgens
Journal:  Atherosclerosis       Date:  1985-12       Impact factor: 5.162

7.  Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.

Authors:  A Gurakar; J M Hoeg; G Kostner; N M Papadopoulos; H B Brewer
Journal:  Atherosclerosis       Date:  1985-11       Impact factor: 5.162

8.  Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B.

Authors:  J R Guyton; G H Dahlen; W Patsch; J A Kautz; A M Gotto
Journal:  Arteriosclerosis       Date:  1985 May-Jun

9.  Studies on the role of specific cell surface receptors in the removal of lipoprotein (a) in man.

Authors:  F Krempler; G M Kostner; A Roscher; F Haslauer; K Bolzano; F Sandhofer
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a).

Authors:  G M Fless; M E ZumMallen; A M Scanu
Journal:  J Biol Chem       Date:  1986-07-05       Impact factor: 5.157

View more
  90 in total

1.  Lipoprotein (a) metabolism estimated by nonsteady-state kinetics.

Authors:  K G Parhofer; T Demant; M M Ritter; H C Geiss; M Donner; P Schwandt
Journal:  Lipids       Date:  1999-04       Impact factor: 1.880

Review 2.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

3.  Hypercholesterolemia and Dyslipidemia.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-04

4.  A proximal tissue-specific module and a distal negative regulatory module control apolipoprotein(a) gene transcription.

Authors:  Sarita Negi; Saurabh K Singh; Nirupma Pati; Vikas Handa; Ruchi Chauhan; Uttam Pati
Journal:  Biochem J       Date:  2004-04-01       Impact factor: 3.857

Review 5.  Lipoprotein(a): its inheritance and molecular basis of its atherothrombotic role.

Authors:  A M Scanu
Journal:  Mol Cell Biochem       Date:  1992-08-18       Impact factor: 3.396

6.  Lp(a): a link between thrombosis and atherosclerosis.

Authors:  A M Scanu
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

7.  Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a).

Authors:  C Sandholzer; G Feussner; J Brunzell; G Utermann
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

8.  Changes in lipoprotein(a), oxidized phospholipids, and LDL subclasses with a low-fat high-carbohydrate diet.

Authors:  Nastaran Faghihnia; Sotirios Tsimikas; Elizabeth R Miller; Joseph L Witztum; Ronald M Krauss
Journal:  J Lipid Res       Date:  2010-08-16       Impact factor: 5.922

9.  Evidence that the fibrinogen binding domain of Apo(a) is outside the lysine binding site of kringle IV-10: a study involving naturally occurring lysine binding defective lipoprotein(a) phenotypes.

Authors:  O Klezovitch; C Edelstein; A M Scanu
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

10.  Convergent evolution of apolipoprotein(a) in primates and hedgehog.

Authors:  R M Lawn; K Schwartz; L Patthy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.